Program for all days

Better Kidney Health

The Interconnected Kidney

The Kidney Losing Function

The Smart Kidney

Plenary Sessions

Pre-congress Courses
(additional fee)

Special Sessions

Spotlight Sessions

Industry Symposia

Global Kidney Policy Forum

Welcome Reception

Topical Networking

Poster Sessions

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course IK01 GeorgiAbraham Chair abraham_georgi@yahoo.comIndiaMGM Healthcare, Chennai, India KriangTungsanga Chair ThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity SanjayD'Cruz Chair sanjaydcruz@gmail.comIndiaGovernment Medical College & Hospital, Chandigarh Renal Complications of Novel Cancer Therapies: Practical Insights IK01-01 AnushreeShirali Speaker United StatesYale University Immune Checkpoint Inhibitors and AKI IK01-02 MitchellRosner Speaker United StatesUniveristy of Virginia Health Electrolyte Abnormalities in the Cancer Patient IK01-03 JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland Opening an Onconephrology Clinic - What Should You Be Aware of? IK01-04 KenarJhaveri Speaker United StatesNorthwell Health Q&A IK01-05 Amaltas Hall B101-A	New Directions in CKD Management: A Case-based Look at the 2024 KDIGO Guidelines. ISN-KDIGO Joint Session BKH2001 IfeomaUlasi Chair NigeriaCollege of Medicine, University of Nigeria Sanjib KumarSharma Chair NepalBP Koirala Institute of Health Sciences ShubharthiKar Chair BangladeshHabiganj Medical College,Bangladesh Detecting and Monitoring CKD Progression BKH2001-01 ElkeSchaeffner Speaker Elke.Schaeffner@charite.deGermanyCharité Universitätsmedizin Berlin, Germany How to Slow and Prevent Kidney and Cardiovascular Complications BKH2001-02 Magdalena Madero Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiologia Ignachi Chavez Managing Complex CKD Cases With Multiple Comorbidities BKH2001-03 NatashaMcIntyre Speaker Natasha.McIntyre@lhsc.on.caCanadaClinician Scientist, London Health Sciences Centre, London, Canada Quality of Life in CKD: The Role of Drug Stewardship and Symptom Management BKH2001-04 TeerawatThanachayanont Speaker tthanachayanont@gmail.comThailandBhumirajanagarindra Kidney Institute Hospital Q&A BKH2001-05 Amaltas Hall B101-B			Genetic Kidney Diseases: Current Trends and Future Perspectives. ISN-JSN Joint Session SK2001 PrabirRoy-Chaudhury Chair prabir@email.unc.eduUnited StatesUniversity of North Carolina and Salisbury VAMC Raja Ramachandran Chair drraja1980@gmail.comIndiaAssociate Professor ReikoInagi Chair JapanThe University of Tokyo Graduate School of Medicine Genetic Variants in Kidney Diseases SK2001-01 TomokoHorinouchi Speaker tomoko.hatono@gmail.comJapanDepartment of Pediatrics, Kobe University Graduate School of Medicine Molecular Data and Genetic Discoveries in Kidney Diseases SK2001-02 KrzysztofKiryluk Speaker kk473@columbia.eduUnited StatesColumbia University Trends in Diagnosing Genetic Kidney Diseases SK2001-03 EiseiSohara Speaker JapanInstitute of Science Tokyo Metabolism of Genetic Kidney Diseases (Pathogenic Podocyte Lipid Metabolism of Alport Syndrome) SK2001-04 AlessiaFornoni Speaker United StatesUniversity of Miami Q&A SK2001-05 Brahmkamal Hall - Plenary Hall	Hot Topics From the Tropics YN SabineKaram Chair United StatesUniversity of Minnesota SourabhSharma Chair IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Best Abstract Winner - Basic Science: miRNA Profiling of Urinary Exosomes for Predicting Renal Outcome After Acute Kidney Injury: A Pilot Study YN-01 JaskiranKaur Oral Abstract Presenter IndiaDepartment of Experimental Medicine and Biotechnology Best Abstract Winner - Clinical Science: Randomised Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults With Steroid-Dependent Idiopathic Nephrotic Syndrome YN-02 AndreaAngeletti Oral Abstract Presenter Italy Q and A YN-03 Everything You Ever Wanted to Know About Tropical Infections and the Kidney YN-04 MythriShankar Speaker IndiaInstitute of Nephrourology Challenges in the Tropics: When CKDu Becomes Less Unknown YN-05 ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo Roundtable Discussion YN-06 BiancaDavidson Speaker South AfricaGroote Schuur Hospital, University of Cape Town ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo MythriShankar Speaker IndiaInstitute of Nephrourology SourabhSharma Speaker IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Champa Hall 304		CKD-MBD Insights and Innovations for 2025 and Beyond: No Bone Left Uncovered LF01 ArvindBagga Chair arvindbagga@hotmail.comIndia UttaraDas Chair uttaradas806@gmail.comIndiaAll IndiaInstitute of Medical Science Mangalagiri What Should a Clinician Know About CKD-MBD in 2025? LF01-01 HanneJoergensen Speaker hsjorgensen@clin.au.dkDenmarkAarhus University CKD-MBD in Children and Young Adults: What's the Difference? LF01-02 SukanyaGovindan Speaker IndiaMehta Children's Hospitals and MGM healthcare, Chennai, India Progress in CKD-driven Vascular Calcification: From Bench to Bedside LF01-03 MarcVervloet Speaker NetherlandsRadboud University Medical center, The Netherlands How to Use Serum Biomarkers for Optimal Management of CKD-MBD LF01-04 SandroMazzaferro Speaker sandro.mazzaferro@uniroma1.itItalySapienza University of Rome, Italy Q&A LF01-05 Gulmohar Hall 302		Measuring Healthcare Transition Readiness to Adult-Focused Care Among Solid Organ Pediatric Transplant Recipients IPTA AhmedMitwallii Chair amitwalli2002@yahoo.comSaudi Arabia AnandChellappan Chair anandchellappan@aiimsnagpur.edu.inIndiaAll India Institute of Medical Sciences, Nagpur AsiriS Abeyagunawardena Chair asiriabey26@gmail.comSri LankaUniversity of Peradeniya Dharmendra singhBhadauriya Chair docdharm10@gmail.comIndia Harbir SinghKohli Chair kohlihs2009@gmail.comIndiaProfessor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, India IndiraAgarwal Chair indiraagarwal@cmcvellore.ac.inIndiaChristian Medical College KhalidAlhasan Chair kalhasan@ksu.edu.saSaudi Arabia RajivSinha Chair rajivsinha_in@yahoo.comIndiaProf ,Pediatrics, HOD , Division of Pediatric Nephrology, institute of Child Health,Kolkata,India RandulaRanawaka Chair rrandula@yahoo.comSri Lanka RukshanaShroff Chair United KingdomMD, FRCPCH, PhD Shyam BihariBansal Chair IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Withanage Dona Vindya NandaniGunasekara Chair vindyaa@hotmail.comSri Lanka Medication Non-adherence Continuinty Care Lost in Transition IPTA-1 AhmedMitwallii Chair amitwalli2002@yahoo.comSaudi Arabia Harbir SinghKohli Chair kohlihs2009@gmail.comIndiaProfessor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, India KhalidAlhasan Chair kalhasan@ksu.edu.saSaudi Arabia VikasDharnidharka Speaker vikas.D@rutgers.eduUnited StatesRutgers Robert Wood Johnson Medical School Transition Tools and Efficacy IPTA-2 AsiriS Abeyagunawardena Chair asiriabey26@gmail.comSri LankaUniversity of Peradeniya RukshanaShroff Chair United KingdomMD, FRCPCH, PhD Shyam BihariBansal Chair IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India RupeshRaina Speaker RRaina@akronchildrens.orgUnited States What Does Transition Mean for LMIC: Challenges IPTA-3 Dharmendra singhBhadauriya Chair docdharm10@gmail.comIndia RandulaRanawaka Chair rrandula@yahoo.comSri Lanka Kar HuiNg Speaker SingaporeDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore Multidisplinary Approach IPTA-4 AnandChellappan Chair anandchellappan@aiimsnagpur.edu.inIndiaAll India Institute of Medical Sciences, Nagpur IndiraAgarwal Chair indiraagarwal@cmcvellore.ac.inIndiaChristian Medical College Withanage Dona Vindya NandaniGunasekara Chair vindyaa@hotmail.comSri Lanka PriyaVerghese Speaker United StatesProfessor, Division Chief Q and A Kesar Hall 202		Integrating Knowledge From Large-scale Data Sets in Your Research Strategy: Introduction to the Hands-on Big Data Lab at WCN'25 SS1 MatthiasKretzler Chair United StatesUniversity of Michigan ShrutiTapiawala Chair shruti16374@gmail.comIndiaGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, Mumbai Artificial and Human Intelligence Work Best Together: Pathomics in 2025 SS1-01 LauraBarisoni Speaker United StatesDuke University Mapping Molecular Data Sets on Clinical Profiles SS1-02 VijiNair Speaker United States The Kidney Precision Medicine Project (KPMP) Kidney Tissue Atlas: Latest Developments SS1-03 SanjayJain Speaker sanjayjain@wustl.eduUnited StatesWashington University School of Medicine Introduction to the Hands-on Big Data Lab SS1-04 HeatherAscani Speaker United StatesUniversity of Michigan NikkiBonevich Speaker United StatesUniversity of Michigan VijiNair Speaker United States Kumudini Hall 301	Planetary and Kidney Health: It is a Two-Way Journey BKH01 GermaineWong Chair AustraliaUniversity of Sydney MariaPippias Chair maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol SwaminathanSundararaman Chair India People, the Planet, and Nephrology - the Impact of Environmental Change on Kidney Health BKH01-01 Giorgina BarbaraPiccoli Speaker GBPICCOLI@YAHOO.ITFranceCentre Hospitalier Le Mans How to Develop a Roadmap for Environmentally Sustainable Kidney Care BKH01-02 KatherineBarraclough Speaker katherine.barraclough@mh.org.auAustraliaMelbourne Health How Do I Make My Dialysis Unit More Environment-friendly? BKH01-03 TanujLamech Speaker tanujlamech@gmail.comIndiaSRM Medical College Hospital and Research Centre What Will Kidney Care Look Like 25 Years From Now? The Role of Future Generations BKH01-04 Winston Wing ShingFung Speaker Hong Kong, ChinaPrince of Wales Hospital, Hong Kong Q&A BKH01-05 Neelkamal Hall 305			State of the Art Insights Into Pregnancy and Pediatric Thrombotic Microangiopathies IK1001 ArvindBagga Chair arvindbagga@hotmail.comIndia DavidKavanagh Chair United KingdomNational Renal Complement Therapeutics Centre VinayRathore Chair IndiaAll India Institute of Medical Sciences- Raipur Outcomes From the ISN Haemolytic Uraemic Syndromes Forum: A Comprehensive Review IK1001-01 DavidKavanagh Speaker United KingdomNational Renal Complement Therapeutics Centre Differential Diagnosis and Treatment of TMAs in Pregnancy IK1001-02 ShilpanjaliJesudason Speaker AustraliaRoyal Adelaide Hospital and Adelaide University, Australia Factor H Autoantibodies in aHUS IK1001-03 AditiSinha Speaker aditisinhaaiims@gmail.comIndiaDepartment of Pediatrics, All India Institute of Medical Sciences aHUS in Paediatric Populations IK1001-04 Lap Tak Alison MA Speaker Hong Kong, ChinaHong Kong Children\'s Hospital Q&A IK1001-05 Parijat Hall 201
11:15 a.m. 12 p.m.	Big Data Lab 1 - Your Gateway to Transcriptomic Analysis in Kidney Disease Research: Nephroseq LAB-01 Big Data Lab								Industry Spotlight Session SPOT-I-1 Spotlight One (Exhibition)
11:45 a.m. 12:45 p.m.	Plenary Session 2: Mathematics as a Microscopy: Modeling Kidney Disease (Anita Layton, Canada) PL2 AgnesFogo Chair United States SabineKaram Chair United StatesUniversity of Minnesota Shyam BihariBansal Chair IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Roscoe Robinson Award PL2-1 ShilpanjaliJesudason Awardee AustraliaRoyal Adelaide Hospital and Adelaide University, Australia Mathematics as a Microscopy: Modeling Kidney Disease. Stewart Cameron Lecture PL2-2 AnitaLayton Speaker anita.layton@uwaterloo.caCanadaUniversity of Waterloo Schrier Award PL2-3 GirishBhatt Awardee IndiaAll India Institute of Medical Sciences (AIIMS), Bhopal, M.P, India Brahmkamal Hall - Plenary Hall
1 p.m. 2 p.m.	Industry Symposium Amaltas Hall B101-A			Industry Symposium Amaltas Hall B101-B			Industry Symposium Kumudini Hall 301				Improving Renal Pathology Services in Rwanda – a Case Study on the Impact of the ISN Fellowship Program (40 years old!) SL04 RolandoClaure Del Granado Spotlight Chairperson rclaure@yahoo.comBoliviaDivision of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba EtienneNtabanganyimana Spotlight Speaker ntet07@yahoo.frRwanda Ntakirutimana Gervais Spotlight Speaker gentaki2000@yahoo.frRwanda SantoshVarughese Spotlight Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore SwarnalataGowrishankar Spotlight Speaker swarnalatag@gmail.comIndia Spotlight One (Exhibition)			ISN Community Film Event SL05 MarinaWainstein Chair ArgentinaAcademia Nacional de Medicina de Buenos Aires Spotlight Two (Amphitheatre, level 5)
1:30 p.m. 2:15 p.m.	Glomerular Disease Jeopardy SL06 Spotlight One (Exhibition)								What Can Be Achieved in the Sister Center Partnerships? SL05A RukshanaShroff Spotlight Chairperson United KingdomMD, FRCPCH, PhD GirishBhatt Spotlight Speaker IndiaAll India Institute of Medical Sciences (AIIMS), Bhopal, M.P, India Pukar ChandraShrestha Spotlight Speaker pcshrestha@yahoo.co.ukNepal SUSANUTHUP Spotlight Speaker uthupsusan5@gmail.comIndia Spotlight Two (Amphitheatre, level 5)
2:15 p.m. 3:45 p.m.	Xenotransplantation - the Brave New World of Farm to Clinic SK01 Christoph Wanner Chair GermanyUniversity SishirGang Chair sishirgang@hotmail.comIndia The First Pig to Human Transplant SK01-01 LeonardoRiella Speaker lriella@mgh.harvard.eduUnited StatesHarvard Medical School, Massachusetts General Hospital Infectious Challenges in Xenotransplant SK01-02 AtulHumar Speaker atul.humar@uhn.caCanadaUniversity of Toronto Ethical Challenges of Xenotransplantation SK01-03 DominiqueMartin Speaker AustraliaDeakin University Q&A SK01-04 Amaltas Hall B101-A	Unraveling the Cardiovascular-Kidney-Metabolic Nexus: Making All Work Together for Kidney Care IK02 Parminder KaurJudge Chair parminder.judge@ndph.ox.ac.ukUnited KingdomUniversity of Oxford, UK VineetBehera Chair beheravineet@gmail.comIndiaConsultant Nephrologist & Professor Medicine, INHS Kalyani, Visakhapatnam Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean? IK02-01 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology GLP-1 RA in Kidney Disease: Beyond T2DM Control IK02-02 BeatrizFernandez-Fernandez Speaker SpainHospital Universitario Fundación Jimenez Díaz New Frontiers in CKD Therapy: Endothelin Receptor Antagonists IK02-03 Maria JoseSoler Speaker SpainHospital del Vall d´Hebron Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know? IK02-04 Sydney Tang Speaker Hong Kong, ChinaThe University of Hong Kong Q&A IK02-05 Amaltas Hall B101-B			HIT! High Impact Clinical Trials – What and Why HIT1 Andrea Viecelli Chair SwitzerlandUniversity Hospital of Zurich VivekKumar Chair IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) HIT1-1 RajivAgarwal Oral Abstract Presenter United States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis HIT1-2 BradRovin Oral Abstract Presenter United StatesThe Ohio State University Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial HIT1-3 KatherineTuttle Oral Abstract Presenter United StatesUniversity of Washington School of Medicine, Division of Nephrology Brahmkamal Hall - Plenary Hall	Bridging the Gap: PKD Research and Clinical Care Perspective. Kaplan PKD Session KAPLAN VicenteTorres Chair United StatesMayo Clinic Welcome and Introduction of the Lillian Jean Kaplan Prize for PKD KAPLAN-01 VicenteTorres Speaker United StatesMayo Clinic Preclinical Findings of PKD Mechanism to Therapy Designs and Testing KAPLAN-02 MarieTrudel Speaker marie.trudel@umontreal.caCanada Perspective on PKD Research and Clinical Care in India KAPLAN-03 SwaminathanSundararaman Speaker India Roundtable Discussion KAPLAN-04 AndrewMallett Speaker andrew.mallett@health.qld.gov.auAustraliaJCU & THHS BillWang Speaker Hong Kong, ChinaISN Patient Liaison Advisory Group MarieTrudel Speaker marie.trudel@umontreal.caCanada SwaminathanSundararaman Speaker India Champa Hall 304		Improving Global Understanding and Achieving Equity in Peritoneal Dialysis Practices: ISN-DOPPS Joint Session LF2001 AmitGupta Chair dramitguptanephropgi@gmail.comIndiaChairman Department of Nephrology & Renal Transplantation, Apollomedics Superspeciality Hospital, Lucknow, India RitaSuri Chair CanadaMcGill University RobertoPecoits-Filho Chair United StatesArbor Research Collaborative for Health PDOPPS: Where Are We 10 Years Later? LF2001-01 RobertoPecoits-Filho Speaker United StatesArbor Research Collaborative for Health Kidney Health for Women on Peritoneal Dialysis: Insights from PDOPPS LF2001-02 EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust Was the PD-First Policy in Thailand Justified? Insights From the PDOPPS LF2001-03 TalerngsakKanjanabuch Speaker ThailandFaculty of Medicine, Chulalongkorn University Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? Yes LF2001-04 JeffreyPerl Speaker jeff.perl@utoronto.caCanadaSt. Michael's Hospital Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? No LF2001-05 RashaDarwish Speaker EgyptKasr Aleiny medical school , Cairo University Q&A/Panel Discussion LF2001-06 Gulmohar Hall 302		Bridging the Clinical Gap: Sustainable Strategies and Innovative Therapies for Global Kidney Health BKH02 ErangaWijewickrama Chair Sri LankaFaculty of Medicine, University of Colombo Prof (Dr ) SanjeevGulati Chair sgulati2002@gmail.comIndiaExecutive Director Nephrology and Kidney Transplant, Fortis gp of Hospitals and Adjunct Professor, Manipal University Sustainable Community Approaches to Early CKD Detection BKH02-01 RonaldGansevoort Speaker NetherlandsDept. Nephrology, University Medical Center Groningen Kidney Disease Treatment Gaps Worldwide - Where Are the Solutions? BKH02-02 AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care The Promise of Emerging Therapies in Reducing the Global Kidney Disease Burden BKH02-03 DavidWheeler Speaker United KingdomUniversity College London Co-opting Patients as Partners in Kidney Care: How Do We Do It? BKH02-04 ShilpanjaliJesudason Speaker AustraliaRoyal Adelaide Hospital and Adelaide University, Australia Co-opting Patients as Partners in Kidney Care: How Do We Do It? BKH02-05 ShyamsundarMuthuramalingam Speaker Shyamsundar.Muthuramalingam@sa.gov.auAustraliaCentral Adelaide Local Health Network Q&A BKH02-06 Kesar Hall 202		Managing Rare Kidney Diseases Across the Lifespan: From Childhood to Adulthood SK1001 Jonathan Barratt Chair United KingdomUniversity of Leicester, Leicester, UK New Innovations and Best Practices for Rare Kidney Disease SK1001-01 Jonathan Barratt Speaker United KingdomUniversity of Leicester, Leicester, UK How Can the CureGN and NEPTUNE Help Us Better Understand Rare Kidney Disease SK1001-02 MatthiasKretzler Speaker United StatesUniversity of Michigan Using Patient Registry Data to Fight Rare Kidney Diseases SK1001-03 DanielGale Speaker United KingdomUniversity College London Living With Rare Kidney Disease in Africa: Experiences and Challenges SK1001-04 IfeomaUlasi Speaker NigeriaCollege of Medicine, University of Nigeria Q&A SK1001-05 Kumudini Hall 301	Innovative Interventions in Interventional Nephrology LF02 Arup Ratan Dutta Chair duttascomplex@gmail.comIndia CarmenTzanno Branco Martins Chair tzanno@gmail.comBrazilSLANH, ISN TusharVachharajani Chair tvachh@gmail.comUnited StatesJohn D. Dingell Veterans Affairs Medical Center / Wayne State University School of Medicine Multi-organ POCUS in AKI LF02-01 AbhilashKoratala Speaker akoratala@mcw.eduUnited States Changing Paradigms in Dialysis Vascular Access - What Should the Current Day Nephrologist Know? LF02-02 VandanaNiyyar Speaker United StatesEmory University The Need for a Structured POCUS Program for the Nephrology Trainee LF02-03 EduardoRios Argaiz Speaker MexicoInstituto Nacional de Ciencias Médicas y Nutrición How to Set Up an Interventional Nephrology Service With Limited Resources LF02-04 MayuriTrivedi Speaker mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India Q&A LF02-05 Neelkamal Hall 305			How Do I…? Practical Approaches to Kidney Care Challenges IK2001 LilyMushahar Chair MalaysiaIMU University and Hospital Tuanku Ja'afar Seremban, Malaysia SudarshanBallal Chair s.ballal@manipalhospitals.comIndiaNephrologist and Chairman, Manipal Hospitals, India, Bengaluru How Do I…Set Up and Implement Multidisciplinary Kidney Care? IK2001-03 IfeomaUlasi Speaker NigeriaCollege of Medicine, University of Nigeria How Do I…Manage Kidney Transplant Recipients Who Are Losing Their Graft? IK2001-02 SunitaBavanandan Speaker MalaysiaHospital Kuala Lumpur, Malaysia How Do I…Get Pregnant With Kidney Disease? IK2001-01 SilviShah Speaker silvishah2108@gmail.comUnited StatesUniversity of Cincinnati, Ohio, United States How Do I…Conduct Immune Risk Stratification of Potential Kidney Transplant Recipients? IK2001-04 AjayKher Speaker ajay1kher@gmail.comIndiaEpitome Kidney Urology Institute And Lions Hospital, Delhi How Do I…Design and Implement Large Simple Trials? IK2001-05 MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Q&A IK2001-06 Parijat Hall 201
3:45 p.m. 4:30 p.m.	Big Data Lab 2 - Deepen your understanding of CKD and AKI in healthy and diseased kidneys: The Kidney Precision Medicine Project (KPMP) Kidney Tissue Atlas LAB-02 Big Data Lab					Industry Spotlight Session SPOT-I-2 Spotlight One (Exhibition)						Easing the Treatment Burden: The Nurse's Role in Patient and Caregiver Support SL09 Ana Elizabeth Figueiredo Spotlight Chairperson BrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Spotlight Speaker elaine.bowes@nhs.netUnited KingdomKing's College Hospital Fatimade Figueiredo Spotlight Speaker f.defigueiredo@nhs.netUnited Kingdom Janevan der Jeugd Spotlight Speaker jane.vanderjeugd@sa.gov.auAustraliaFlinders Medical Centre, Adelaide, South Australia ZehraAydin Spotlight Speaker TurkeyIstanbul Atlas University Spotlight Two (Amphitheatre, level 5)
4:15 p.m. 5:15 p.m.	CKD Screening: A Universal Necessity or a Targeted Approach? The Great Debate; ISN-ERA Special Session BKH03 AminuBello Chair CanadaUniversity of Alberta HarunUr Rashid Chair rashid@bol-online.comBangladeshKidney Foundation Hospital and Research Institute VijayKher Chair kherv1968@gmail.comIndiaEpitome Kidney & Urology Institute, New Delhi Hot Debate - We Should Have Universal Screening For CKD: ISN-ERA Special Lecture - PRO BKH03-01 AlbertoOrtiz Speaker SpainIIS-Fundacion Jimenez Diaz UAM, Madrid, Spain Hot Debate - We Should Have Universal Screening For CKD: ISN-ERA Special Lecture - CON BKH03-02 GermaineWong Speaker AustraliaUniversity of Sydney Amaltas Hall B101-A		Autoimmunity in Glomerular Diseases - Looking Beyond the Kidney SK02 MaartenTaal Chair maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham ShrutiTapiawala Chair shruti16374@gmail.comIndiaGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, Mumbai Anti-nephrin Antibodies - What Do We Know and What Can We Look Forward to? SK02-01 TobiasHuber Speaker GermanyUniversity Medical Center Hamburg-Eppendorf Mechanism of IgA Deposition in the Mesangium: Implication for Novel Treatments SK02-02 Yoshihito Nihei Speaker JapanDepartment of Nephrology, Juntendo University Faculty of Medicine Lupus Nephritis: Recent Advances in Pathogenesis and New Therapeutic Approaches SK02-03 LizLightstone Speaker United KingdomImperial College London Q&A SK02-04 Brahmkamal Hall - Plenary Hall			Hot Debate: In This New Era of Artificial Intelligence, Do We Need Renal Pathologists? SK03 GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India Ritambhra NadaDUSEJA Chair ritamduseja@yahoo.comIndiaPGIMER,CHANDIGARG,INDIA SuryaSeshan Chair United StatesWeill Cornell Medicine Hot Debate: In This New Era of Artificial Intelligence, We No Longer Need Renal Pathologists - PRO SK03-01 KimSolez Speaker Canada Hot Debate: In This New Era of Artificial Intelligence, We No Longer Need Renal Pathologists - CON SK03-02 AgnesFogo Speaker United States Champa Hall 304			Real World Ethics: When It's Hard to Be Good BKH2002 DominiqueMartin Chair AustraliaDeakin University Elliot KorantengTannor Chair GhanaKwame Nkrumah University of Science and Technology MadhukarMisra Chair misram@health.missouri.eduUnited StatesUniversity of Missouri Columbia, USA Introduction: the Difficulty of Translating Ethical Ideals in the Real World BKH2002-01 DominiqueMartin Speaker AustraliaDeakin University Case Study 1: The Disruptive Dialysis Patient BKH2002-02 IanDittmer Speaker idittmer@adhb.govt.nzNew ZealandTe Whatu Ora - Health New Zealand Case Study 2: The Dodgy Doctor BKH2002-03 PriyaPais Speaker IndiaDepartment of Pediatric Nephrology, St John's Medical College, Bengaluru (Bangalore), India Case Study 3: The Insistent Family BKH2002-04 GhadaAnkawi Speaker Saudi ArabiaKing Abdulaziz University Q and A, and Conclusion: Ethical Recommendations for Real World Practice BKH2002-05 Gulmohar Hall 302			Exploring Complement System Dynamics: C3G and IgAN SK1002 AmitGovil Chair amit.govil@uc.eduUnited StatesUniversity of Cincinnati HernánTrimarchi Chair ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES S AnanthKarumanchi Chair SAnanth.Karumanchi@csmc.eduUnited StatesCedars-Sinai Medical Center The Complement System in C3G and IgAN: A Pathophysiologic Perspective SK1002-01 HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES The Complement System in C3G: Updated Therapeutic Approaches SK1002-02 DavidKavanagh Speaker United KingdomNational Renal Complement Therapeutics Centre The Complement System in IgAN: An Updated Therapeutic Approach SK1002-03 HeatherReich Speaker CanadaUniversity of Toronto, University Health Network Q&A SK1002-04 Kumudini Hall 301			Are Your Kidneys OK? Early CKD Detection and Key Advocacy Strategies. WKD Joint Session BKH1001 Augusto CesarSoares dos Santos Junior Chair BrazilHospital das Clinicas, UFMG; Fac Ciências Medicas LathaKumaraswami Chair info@ifkf.orgIndiaPast President, IFKF-WKA; Managing Trustee TANKER Foundation, India Primary Kidney Disease Prevention: The 8 Golden Rules BKH1001-01 DinaAbdellatif Speaker EgyptCairo University Hospital Proactive Kidney Health: The Return on Investment of Early Detection BKH1001-02 JosephVassalotti Speaker joseph.vassalotti@mountsinai.orgUnited StatesIcahn School of Medicine at Mount Sinai Kidney Health Across Ages: Comparing Risk Factors in Adults and Pediatrics BKH1001-03 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland Kidney Awareness: Engaging Patients for Better Outcomes BKH1001-04 VasundharaRaghavan Speaker vasundhara.raghavan@gmail.comIndiaMember of PLAG Q&A BKH1001-05 Neelkamal Hall 305
5:15 p.m. 6 p.m.	Big Data Lab 3 - Discover the latest Spatial Biology and Digital Pathology tools and techniques specifically designed for renal research. LAB-03 Big Data Lab
5:30 p.m. 6:30 p.m.	Poster Session POS-1 Exhibition Hall					Meet the Experts Kesar Hall 202						Young Nephrologists Quiz-a-Thon III SL10 Spotlight One (Exhibition)

Saturday, February 8, 2025

Time	Session

8:30 a.m. 9:30 a.m.	Industry Symposium Amaltas Hall B101-A	Industry Symposium Champa Hall 304	Meet the Experts Kesar Hall 202	Industry Symposium Kumudini Hall 301	Industry Symposium Neelkamal Hall 305
9:45 a.m. 11:15 a.m.	Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session IK03 GirishNarayen Chair girishnarayan49@gmail.comIndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India Hyeong CheonPark Chair Korea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University Prem PrakashVarma Chair IndiaPrincipal Director What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes? IK03-01 Chi-yuanHsu Speaker United StatesUniversity of California, San Francisco Are Biomarkers in AKI Ready for Prime Time? IK03-02 ChiragParikh Speaker chirag.parikh@jhmi.eduUnited StatesJohns Hopkins University Community-acquired AKI in the Tropics - Is it a Different Disease? IK03-03 VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Sex as a Biological Variable in the Epidemiology of AKI IK03-04 MarliesOstermann Speaker United KingdomKing's College London Q&A IK03-05 Amaltas Hall B101-A	Anemia Management: Paradigm Shift or Hype? LF03 DineshKhullar Chair India Fatiu AbiolaArogundade Chair fatiu3@yahoo.comNigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India Guideline-based Treatment of Anaemia of CKD: What's New? LF03-01 Kai-UweEckardt Speaker GermanyDepartment of Nephrology and Medical Intensive Car HIF-PHIs: Two Sides of the Same Coin LF03-02 Chuan-MingHao Speaker ChinaFudan University Huashan Hospital Iron Therapy in CKD: Moving Targets LF03-03 EviNagler Speaker evi.nagler@ugent.beBelgiumNephrology Department, Ghent University Hospital, Consequences of Iron Overload LF03-04 RobertKalyesubula Speaker UgandaMakerere, University Q&A LF03-05 Amaltas Hall B101-B	Debunking Nephrology Myths: Insights From Global Kidney Care Leaders BKH2003 SanjayPandya Chair saveyourkidney@gmail.comIndiaConsulting Nephrologist, Wockhardt Hospital & Jalaram Hospital, Rajkot SreejithParameswaran Chair sparameswaran@outlook.comIndiaProfessor & Head, Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Revisiting Kidney Biopsies: Why More Than One Can Be Beneficial BKH2003-01 BradRovin Speaker United StatesThe Ohio State University Genetic Testing for Kidney Disease Is Not Complicated BKH2003-02 KelsieBogyo Speaker kb3164@cumc.columbia.eduUnited StatesColumbia University Irving Medical Center Thrombotic Microangiopathy Workup: Everything You Need to Know BKH2003-03 AnujaJava Speaker United StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS Dealing With Biological Variability in Albuminuria and Creatinine BKH2003-04 SusrutWaikar Speaker swaikar@partners.orgUnited StatesBoston University Chobanian and Avedisian School of Medicine, and Boston Medical Center The Underdiagnosis of Primary Aldosteronism in Clinical Practice BKH2003-05 VivekBhalla Speaker vbhalla@stanford.eduUnited StatesDirector, Stanford Hypertension Center; Division of Nephrology, Stanford University School of Medicine Q&A BKH2003-06 Brahmkamal Hall - Plenary Hall	The ISN-KI/KIR Editorial Fellows Session: The Best of 2024/25 Articles KI/KIR1 BradRovin Chair United StatesThe Ohio State University GermaineWong Chair AustraliaUniversity of Sydney PierreRonco Chair FranceHôpital Tenon Kidney International in Focus: Annual Highlights KI/KIR1-01 PierreRonco Speaker FranceHôpital Tenon ISN-KI Fellows: Showcasing Excellence Part 1 KI/KIR1-02 Eugene Yu HinChan Speaker Hong Kong, ChinaThe Chinese University of Hong Kong, Hong Kong Children's Hospital ISN-KI Fellows: Showcasing Excellence Part 2 KI/KIR1-03 IsabelleAyoub Speaker isabelle.ayoub@osumc.eduUnited StatesThe Ohio State University ISN-KI Fellows: Showcasing Excellence Part 3 KI/KIR1-04 ChristophKuppe Speaker ckuppe@ukaachen.deGermanyDepartment of Nephrology, RWTH University Aachen, Germany ISN-KI Fellows: Showcasing Excellence Part 4 KI/KIR1-05 GriffithPerkins Speaker Australia Q and A Kidney International Reports in Focus: Annual Highlights KI/KIR1-06 JaiRadhakrishnan Speaker United StatesColumbia University in the City of New York Kidney International Reports in Focus: Annual Highlights KI/KIR1-07 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Kidney International Reports in Focus: Annual Highlights KI/KIR1-08 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland Q and A Celebrating Excellence: Best Reviewer Awards Presentation KI/KIR1-09 BradRovin Speaker United StatesThe Ohio State University Recognizing the Best: Basic Science Awards for Early Career Researchers KI/KIR1-10 VeronicaMiguel Speaker vmiguh00@gmail.comSpainSpanish National Centre for Cardiovascular Research Recognizing the Best: Clinical Science Awards for Early Career Researchers KI/KIR1-11 MuzamilHassan Speaker NigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Recognizing the Best: ISN-KI Editorial Fellows Awards KI/KIR1-12 GermaineWong Speaker AustraliaUniversity of Sydney Champa Hall 304	Pursuing Global Equitable Access to Peritoneal Dialysis: ISN-ISPD Joint Session LF2002 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore AnuragGupta Chair dranuragg1@yahoo.comIndia SimonDavies Chair United KingdomKeele University Peritoneal Dialysis: A Global Epidemiological Perspective LF2002-01 RajnishMehrotra Speaker rmehrotr@u.washington.eduUnited StatesUniversity of Washington What’s Stopping PD Use in South Asia? LF2002-02 PritiMeena Speaker IndiaAll india institute of medical sciences-Bhubaneswar International Home Dialysis Consortium (IHDC) Initiatives: Expanding Global Access to Peritoneal Dialysis LF2002-03 EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust Empowering Nurses to Support Growth of Peritoneal Dialysis Programs LF2002-04 ReenaGeorge Speaker reenarachelgeorge@gmail.comIndiaChristian Medical College Vellore, Tamil Nadu, India Q&A LF2002-05 Gulmohar Hall 302	Making the Case: Investing in Kidney Care for Equity and Access BKH04 AKBhalla Chair bhallaak@yahoo.comIndiaSir Ganga Ram Hospital New Delhi ElenaZakharova Chair helena.zakharova@gmail.comRussiaElena Zakharova, Botkin Hospital, Moscow, Russia MarinaWainstein Chair ArgentinaAcademia Nacional de Medicina de Buenos Aires Empowering Kidney Care Through Advocacy: Strategies and Success Stories BKH04-01 LauraSola Speaker solalaura11@gmail.comUruguayDialysis Center, CASMU-IAMPP How to Convince Your Health Minister to Invest in CKD Prevention BKH04-02 Elliot KorantengTannor Speaker GhanaKwame Nkrumah University of Science and Technology Toward Removal of Socioeconomic Inequities in Kidney Care and Better Outcomes for Children BKH04-03 ArpanaIyengar Speaker IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE How Do We Advocate for Better Access to Kidney Transplantation Worldwide? BKH04-04 IkechiOkpechi Speaker CanadaUniversity of Alberta Q&A BKH04-05 Kumudini Hall 301	Renal Resilience - Recent Advances in Clinical Knowledge and Future Treatment of Rare Orphan Diseases; ISN-CSN Joint Session SK04 ArvindConjeevaram Chair IndiaHead - Nephrology Dept, Trustwell Hospitals, Bangalore DebasishBanerjee Chair dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr How Do I Treat Renal Complications in Patients With Sickle Cell Disease? SK04-01 ClaireSharpe Speaker claire.sharpe@nottingham.ac.ukUnited KingdomUniversity of Nottingham and King's College Hospital, London iPSCs to Model Rare Kidney Diseases for Drug Discovery: The Examples of FSGS and ADPKD SK04-02 ArielaBenigni Speaker ariela.benigni@marionegri.itItalyMario Negri Institute for Pharmacological Research, Italy Kidney Multiome-based Genetic Scorecard Reveals Convergent Coding and Regulatory Variants SK04-03 KatalinSusztak Speaker ksusztak@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania Primary Hyperoxaluria: A Hope for Gene Therapy? SK04-04 YaacovFrishberg Speaker yaacovf@ekmd.huji.ac.ilIsrael Q&A SK04-05 Neelkamal Hall 305	Key Issues in Transplantation in India: Challenges and Opportunities. ISN-Indian SN Joint Session LF2010 AlanFernandes Almeida Chair almeidaa@gmail.comIndiaPD Hinduja Hospital & Medical Research Center, Mumbai SreelathaMelemadathil Chair drrcbabu@gmail.comIndiaGovernment Medical College, Kozhikode TB in Transplant Candidates and Recipients: Diagnosis and Treatment LF2010-01 Shyam BihariBansal Speaker IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Bringing in Personalized Medicine Approaches to Kidney Transplantation: What Is Possible LF2010-02 Harbir SinghKohli Speaker kohlihs2009@gmail.comIndiaProfessor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, India Kidney Transplantation in Children: What Are the Special Issues and How to Navigate Them? LF2010-03 PriyaVerghese Speaker United StatesProfessor, Division Chief Bringing Equity to Transplantation: Barriers, Challenges and Triumphs LF2010-04 NatarajanGopalakrishnan Speaker IndiaTransplant Authority of Tamil Nadu Q and A LF2010-05 Parijat Hall 201
11:15 a.m. 12 p.m.	Big Data Lab 4 - Link Kidney Genetics and Genomics in Experimental Research: NephQTL LAB-04 Big Data Lab	Inside iNET-CKD: Uncovering the Power of Cohort Studies to Understand Ckd Progression and Complications SL11 MaartenTaal Spotlight Chairperson maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham RobertoPecoits-Filho Spotlight Chairperson United StatesArbor Research Collaborative for Health Introducing iNET-CKD: Harnessing Global Cohorts to Transform CKD Research MaartenTaal Spotlight Speaker maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham Exploring iNET-CKD Cohorts: Key Findings from iNET-CKD Studies RobertoPecoits-Filho Spotlight Speaker United StatesArbor Research Collaborative for Health Collaborative Opportunities in CKD Research: Leveraging the iNET-CKD Platform AdeeraLevin Spotlight Speaker CanadaUniversity of British Columbia and Providence Health Care Q and A Spotlight One (Exhibition)	Artificial vs Natural Intelligence in Nephrology with the ISN Emerging Leaders SL12 ChimezieOkwuonu Spotlight Chairperson NigeriaFederal Medical Center DanielO'Hara Spotlight Chairperson AustraliaNHMRC Clinical Trials Centre, Australia Spotlight Two (Amphitheatre, level 5)
11:45 a.m. 12:45 p.m.	Plenary Session 3: Environmental Stressors and Adaptation Mechanisms: From Marine Organism to (Kidney) Health Care (Tamar Lotan, Israel) PL3 AlessiaFornoni Chair United StatesUniversity of Miami Narayan Prasad Chair IndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India VivekanandJha Chair IndiaGeorge Institute for Global Health India Alfred Newton Richards Award PL3-1 ArielaBenigni Awardee ariela.benigni@marionegri.itItalyMario Negri Institute for Pharmacological Research, Italy Environmental Stressors and Adaptation Mechanisms: From Marine Organism to (Kidney) Health Care. Claude Amiel Lecture PL3-2 TamarLotan Speaker lotant@univ.haifa.ac.ilIsraelUniversity of Haifa Fellowship Program Presentation PL3-3 VivekanandJha Chair IndiaGeorge Institute for Global Health India Brahmkamal Hall - Plenary Hall
1 p.m. 2 p.m.	Industry Symposium Amaltas Hall B101-A	Industry Symposium Amaltas Hall B101-B	Industry Symposium Champa Hall 304	Industry Symposium Gulmohar Hall 302	Industry Symposium Kumudini Hall 301	Industry Symposium Neelkamal Hall 305	Industry Symposium Parijat Hall 201
1:15 p.m. 2:15 p.m.	The Kidney Tank 2.0 - The Indian Version. Joint session: ISN, NephJC and NECI SL13 DilushiWijayaratne Spotlight Chairperson Sri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka FernandaArce Spotlight Chairperson Mexico Augusto CesarSoares dos Santos Junior Spotlight Speaker BrazilHospital das Clinicas, UFMG; Fac Ciências Medicas ManjushaYadla Spotlight Speaker IndiaProfessor and Head , Nephrology , Gandhi Medical College , HYDERABAD, INDIA MythriShankar Spotlight Speaker IndiaInstitute of Nephrourology SwapnilHiremath Spotlight Speaker CanadaUniversity of Ottawa Spotlight One (Exhibition)
2:15 p.m. 3:45 p.m.	Is the Future Now? Precision Medicine, Omics and AI for Kidney Health SK05 JolantaMalyszko Chair PolandMedical University of Warsaw, Poland ValentineLobo Chair valentinelobo702@gmail.comIndiaNephrology Unit, King Edward Memorial Hospital, Pune Deciphering the Molecular Development of Kidney Disease: Transition From AKI to CKD SK05-01 SanjayJain Speaker sanjayjain@wustl.eduUnited StatesWashington University School of Medicine KidGen Consortium - Integrating Genomic Medicine Into Care SK05-02 AndrewMallett Speaker andrew.mallett@health.qld.gov.auAustraliaJCU & THHS Metadata Ontology, Knowledge Integration, and Kidney Precision Medicine SK05-03 MatthiasKretzler Speaker United StatesUniversity of Michigan Kidney Health Professionals and AI - Pioneers or Passive Users? SK05-04 GirishNadkarni Speaker girish.nadkarni@mountsinai.orgUnited StatesIcahn School of Medicine at Mount Sinai and the Mount Sinai Health System Q&A SK05-05 Amaltas Hall B101-A	Is it All Fluid? Dialysis Dynamics - HD, HDF, PD LF04 Arpita Roychaudhuri Chair lahiri.arpi@gmail.comIndia DibyaSingh Shah Chair NepalInstitute of Medicine Tribhuvan University Teaching Hospital Lori-AnnFisher Chair JamaicaUniversity of the West Indies, Mona Blood Pressure Management in Dialysis: Is it All Fluid? LF04-01 SandipMitra Speaker rhea2202@aol.comUnited KingdomManchester University Hospitals and University of Manchester, UK What Is a Pragmatic Approach Toward Hemodiafiltration in a Resource-limited Setting? LF04-02 SandeepMahajan Speaker IndiaAll India Institute of Medical Sciences Delhi What Adult Nephrologists Need to Know About Pediatric Dialysis LF04-03 RukshanaShroff Speaker United KingdomMD, FRCPCH, PhD PD in Heart Failure LF04-04 AliAbu-Alfa Speaker abualfa@aub.edu.lbLebanonAmerican University of Beirut and Yale University Q&A LF04-05 Amaltas Hall B101-B	Looking into the Crystal Ball – Where Will We Be 5 Years from Now? SK2002 RajkumarSharma Chair rksnepho206@gmail.comIndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow Swetha RaniKanduri Chair svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA Evaluating Kidney Allograft Dysfunction SK2002-001 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Advances in Glomerular Disease Treatment SK2002-02 Jonathan Barratt Speaker United KingdomUniversity of Leicester, Leicester, UK Risk Prediction in AKI and CKD SK2002-03 NavdeepTangri Speaker ntangri@yahoo.comCanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre Prioritizing Patient-friendly Dialysis SK2002-04 EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust Glomerular Disease Diagnostics SK2002-01 SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Q&A SK2002-06 Brahmkamal Hall - Plenary Hall	Understanding and Managing Renal-Respiratory Critical Conjunctions IK04 ManjushaYadla Chair IndiaProfessor and Head , Nephrology , Gandhi Medical College , HYDERABAD, INDIA Muhammad Rafiqul Alam Chair Bangladesh R KasiVisweswaran Chair rkasivis@yahoo.comIndiaAnanthapuri Hospitals and Research Institute, Trivandrum INDIA Acute Respiratory Distress Syndrome and the Kidney IK04-01 FaeqHusain-Syed Speaker faeq.husain-syed@innere.med.uni-giessen.deGermanyUniversity Hospital Giessen and Marburg GmbH, Giessen, Germany Cellular Plasticity in Pulmonary Fibrosis: Implications for Finding Treatment and Understanding Kidney Fibrosis IK04-02 SahajalDhooria Speaker sahajal@gmail.comIndia Managing Pulmonary Renal Syndromes - What Do the Guidelines Say? IK04-03 VladimirTesar Speaker vladimir.tesar@lf1.cuni.czCzech RepublicCharles University, Prague Pulmonary Infections and Kidney Injury in ICUs IK04-04 RolandoClaure Del Granado Speaker rclaure@yahoo.comBoliviaDivision of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba Q&A IK04-05 Champa Hall 304	Navigating Pregnancy and Kidney Disease: Risks, Benefits, and Global Insights. ISN-WIN/WIN India Joint Session LF2004 LizLightstone Chair United KingdomImperial College London RashaDarwish Chair EgyptKasr Aleiny medical school , Cairo University UrmilaAnandh Chair IndiaAmrita Hospitals, Faridabad, Delhi NCR Patient Presentation LF2004-01 Pregnancy-related AKI – a Lethal Problem LF2004-02 DIVYABAJPAI Speaker IndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India aHUS in Pregnancy - What Do We Know and What Can We Do? LF2004-03 AnujaJava Speaker United StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS Using Pregnancy to Initiate Long-term Kidney Care for Women LF2004-04 SaraladeviNaicker Speaker Saraladevi.Naicker@wits.ac.zaSouth AfricaUniversity of the Witwatersrand Developmental Origins of Kidney Disease: It’s All About Mother LF2004-05 KateBramham Speaker United KingdomKing's College London Panel Discussion with Speakers: How to Change Things? How to Raise Awareness? LF2004-06 Gulmohar Hall 302	Speed Dating with KI/KIR Editors KI/KIR2 BradRovin Chair United StatesThe Ohio State University GermaineWong Chair AustraliaUniversity of Sydney PierreRonco Chair FranceHôpital Tenon Introduction KI/KIR2 -1 PierreRonco Speaker FranceHôpital Tenon Translational Science/Genomics KI/KIR2-2 ChristophKuppe Speaker ckuppe@ukaachen.deGermanyDepartment of Nephrology, RWTH University Aachen, Germany KrzysztofKiryluk Speaker kk473@columbia.eduUnited StatesColumbia University Discovery Science KI/KIR2-3 ReikoInagi Speaker JapanThe University of Tokyo Graduate School of Medicine VeronicaMiguel Speaker vmiguh00@gmail.comSpainSpanish National Centre for Cardiovascular Research Clinical Trials KI/KIR2-4 BradRovin Speaker United StatesThe Ohio State University Crossing the Lines to ‘Acceptance’ in High Impact Kidney Journals KI/KIR2-5 PierreRonco Speaker FranceHôpital Tenon SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Epidemiology/Stats/Policy Forum KI/KIR2-6 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland GermaineWong Speaker AustraliaUniversity of Sydney MuzamilHassan Speaker NigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Kesar Hall 202	Next-Gen Perspectives Debate: Will AI Replace Nephrologists in the Future? YN2 AakashShingada Chair aakashshingada@gmail.comIndia KornchanokVareesangthip Chair ThailandSiriraj Hospital, Mahidol University, Thailand Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong Next-Gen Perspectives Debate: Will AI Replace Nephrologists in the Future? YN2 AlejandroGarcia-Rivera Speaker MexicoHospital General Regional 46 IntissarHaddiya Speaker intissarhaddiya@yahoo.frMoroccoDepartment of nephrology Faculty of medicine and Pharmacy of Oujda Mohammed First University Kyung DonYoo Speaker South KoreaUlsan University Hospital, University of Ulsan College of Medicine / Deputy Director, Disaster Preparedness and Response Committee, The Korean Society of Nephrology MarinaWainstein Speaker ArgentinaAcademia Nacional de Medicina de Buenos Aires Kumudini Hall 301	Advancing Global Transplant Equity: A Health-systems and Patient-centered Approach. ISN-TTS/WIT Joint session LF2003 DominiqueMartin Chair AustraliaDeakin University PINAKI MUKHOPADHYAY Chair IndiaDCH.MD.DM (Nephro, PGI Chandigarh), FICP, FISN, FASN, FRCP(London), Professor and Head, Department of Nephrology,NRS MEDICAL COLLEGE KOLKATA TobyCoates Chair toby.coates@sa.gov.auAustralia Reviewing Transplantation in Tanzania: Barriers to Expansion and Insights for Other African Countries LF2003-01 FransiaMushi Speaker fransiaarda@gmail.comTanzaniaMuhimbili University of Health and Allied Sciences The Role of Infectious Disease Expertise in Improving Utilization and Preserving Grafts LF2003-02 JonathanHand Speaker jonathan.hand@ochsner.orgUnited StatesOchsner Health Day-to-Day Challenges in Providing Kidney Replacement Therapy for Women in Low-income Countries LF2003-03 PritiMeena Speaker IndiaAll india institute of medical sciences-Bhubaneswar Transplantation in Thailand: In-depth Review of Current Activities and Progress LF2003-04 AdisornLumpaopong Speaker adisornuic@yahoo.comThailandOn Behalf of Thai Transplantation Society Q&A LF2003-05 Neelkamal Hall 305	What’s Next in Kidney Care Research? Innovations and Clinical Trials on the Horizon SS2 AdeeraLevin Chair CanadaUniversity of British Columbia and Providence Health Care Andrea Viecelli Chair SwitzerlandUniversity Hospital of Zurich Ajit singhNarula Chair narulaas@gmail.comIndia Novel Trial Designs in Nephrology: Innovations and Structures SS2-01 MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia What’s New in Clinical Trials? SS2-02 DavidWheeler Speaker United KingdomUniversity College London Value of Different Outcomes in the Era of Precision Medicine SS2-03 RobertoPecoits-Filho Speaker United StatesArbor Research Collaborative for Health Conducting Trials in Low and Middle-income Countries SS2-04 SoumitaBagchi Speaker soumita_bagchi@yahoo.co.inIndiaProfessor, Department of Nephrology, All India Institute of Medical Sciences, New Delhi Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct SS2-05 ArpanaIyengar Speaker IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE Q&A SS2-06 Parijat Hall 201
3:45 p.m. 4:30 p.m.	Big Data Lab 5 - Discover the Power of Single-Cell Analysis linked with Clinical Data: CELLxGENE LAB-04 Big Data Lab	Industry Spotlight Session SPOT-I-3 Spotlight One (Exhibition)	Advancing Kidney Research with Registries, Collaborative Efforts, and Impactful Stories (ISN-SharE-RR) SL15 FergusCaskey Spotlight Chairperson United KingdomUniversity of Bristol, UK MariaPippias Spotlight Chairperson maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol Unlocking Insights with ISN-SharE-RR: Advancing Kidney Research through Global Registries FergusCaskey Spotlight Speaker United KingdomUniversity of Bristol, UK Driving Collaboration in Kidney Health: Toolkit and Resources from ISN-SharE-RR MariaPippias Spotlight Speaker maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol Decisions I made while setting up the South African Renal Registry Mogamat RazeenDavids Spotlight Speaker South AfricaStellenbosch University and Tygerberg Hospital Panel Discussion with Fergus, Maria & Razeen Spotlight Two (Amphitheatre, level 5)
4:15 p.m. 5:15 p.m.	Hot Debate - To D or Not to D? Do All Patients With CKD Need Vitamin D Supplementation? LF05 FergusCaskey Chair United KingdomUniversity of Bristol, UK OMKUMAR Chair dromkumar@rediffmail.comIndiaINDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, PATNA UmeshKhanna Chair ubkhanna@gmail.comIndia MD DNB (NEPHROLOGY), Hot Debate: To D or Not to D? All Patients With CKD Need Vitamin D Supplementation - PRO LF05-01 HanneJoergensen Speaker hsjorgensen@clin.au.dkDenmarkAarhus University Hot Debate: To D or Not to D? All Patients With CKD Need Vitamin D Supplementation - CON LF05-02 Mario GennaroCozzolino Speaker mario.cozzolino@unimi.itItalyUniversity of Milan Amaltas Hall B101-B	Hot Debate - The KDIGO BP Targets in CKD Are (Un)Achievable and (Un)Realistic IK05 ArpanaIyengar Chair IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE BeatrizFernandez-Fernandez Chair SpainHospital Universitario Fundación Jimenez Díaz Venkata DakshinamurtyKaligotla Chair kvdm1954@gmail.comIndiaMahatma Sri Ramchandra Centenary Memorial Hospital, Vijayanagar Colony, Hyderabad, INDIA Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - PRO IK05-01 SwapnilHiremath Speaker CanadaUniversity of Ottawa Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - CON IK05-02 IndranilDasgupta Speaker Indranil.Dasgupta@uhb.nhs.ukUnited KingdomConsultant Nephrologist, University Hospitals Birmingham, UK Brahmkamal Hall - Plenary Hall	Connecting Cardio-Kidney-Metabolic Dots: Holistic Approaches to Patient Care IK1002 Denis GeorgesTeuwafeu Chair CameroonUniversity of Buea, Faculty of Health Sciences RobertKalyesubula Chair UgandaMakerere, University RobertoPecoits-Filho Chair United StatesArbor Research Collaborative for Health A Nephrologist Perspective on the Cardio-Kidney-Metabolic Syndrome IK1002-01 JananiRangaswami Speaker nephrologymd1@gmail.comUnited StatesProfessor of Medicine, George Washington University School of Medicine Optimizing CKD Management in the Context of Diabetes and Obesity IK1002-02 RobertoPecoits-Filho Speaker United StatesArbor Research Collaborative for Health Combining Therapies for Cardio-Kidney-Metabolic Conditions: An Integrative Approach IK1002-03 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology Q&A IK1002-04 Champa Hall 304	Implementing Nephrogenetics Across the Globe: ISN-IPNA Joint Session SK2003 LarisaPrikhodina Chair LPrikhodina@yahoo.comRussiaProfessor of Pediatrics, Chair of Division of Inherited & Acquired Kidney Diseases, Veltishev Research Clinical Institute for Pediatrics & Children Surgery, Pirogov Russian National Research Medical University NeveenSoliman Chair neveenase@yahoo.comEgyptCenter of Pediatric Nephrology and Transplantation, Kasr Al Ainy Faculty of Medicine, Cairo University TarunJeloka Chair tjeloka@yahoo.comIndiaMANIPAL HOSPITALS Mapping Nephrogenomic Variation in the Middle East SK2003-01 NeveenSoliman Speaker neveenase@yahoo.comEgyptCenter of Pediatric Nephrology and Transplantation, Kasr Al Ainy Faculty of Medicine, Cairo University Implementing Nephrogenetic Diagnostics in Low-resource Settings SK2003-02 Kar HuiNg Speaker SingaporeDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore Comprehensive Nephrogenetic Diagnostics in Europe: Where Do We Stand in 2025? SK2003-03 Albertien M.Van Eerde Speaker a.vaneerde@umcutrecht.nlNetherlandsDepartment of Genetics, UMC Utrecht, The Netherlands Q and A SK2003-04 Gulmohar Hall 302	Seeing the Kidney Clearly: Solo Treatments and Orchestrated Care Through Evidence, Community, and Policy BKH1002 BrianPereira Chair bjgpereira@gmail.comUnited States GhadaAnkawi Chair Saudi ArabiaKing Abdulaziz University MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Addressing Challenges: Early CKD Detection Strategies and the Role of Research and Development in Global Kidney Health BKH1002-01 AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care A Collaborative Approach to Detecting Kidney Disease Early BKH1002-02 ThomasBlakeman Speaker tom.blakeman@manchester.ac.ukUnited KingdomThe University of Manchester Harnessing Digital Technology: Innovative Tools for Early CKD Detection and Management BKH1002-03 Chinta RamaKrishna Speaker rknephro@gmail.comIndiaChinta Rama Krishna, Vedanta Hospitals Q and A BKH1002-04 Kesar Hall 202	Kidney Disease Prediction and Prevention: Evolving Toward a Kidney Health Revolution BKH05 AlejandroGarcia-Rivera Chair MexicoHospital General Regional 46 AnuradhaRaman Chair ramananu48@gmail.comIndia SabineKaram Chair United StatesUniversity of Minnesota Managing Kidney Disease in Diabetes - Is it the Best of Times? BKH05-01 PeterRossing Speaker DenmarkSteno Diabetes Center Copenhagen Implementation of Risk Prediction Equations to Optimize CKD Care - the Present and the Future BKH05-02 NavdeepTangri Speaker ntangri@yahoo.comCanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre Multisectoral Action for Kidney Disease Prevention BKH05-03 Sri LekhaTummalapalli Speaker lekha.tummalapalli@gmail.comUnited StatesAssistant Professor, Weill Cornell Medicine Q&A BKH05-04 Kumudini Hall 301	What Should I Do? Applying the Declaration of Istanbul Principles to Your Clinical Transplant Practice. ISN-DICG Joint Session BKH2004 KamalSud Chair AustraliaThe University of Sydney Maria AmaliaMatamoros Chair amatamoros@cehcr.comCosta RicaCaja Costarricense del Seguro social SanjayNagral Chair sanjaynagral@gmail.comIndiaex co chair ; Declaration of Istanbul Custodian Group My Patient Wants to Travel Abroad for a Kidney Transplant BKH2004-01 JagbirGill Speaker jsgill2@me.comCanadaUniversity of British Columbia My Patient Received a Kidney Transplant Abroad BKH2004-02 RuthRahamimov Speaker ruth.rahamimov@gmail.comIsraelRabin Medical Center, Petach Tikva, Israel How to Deal With Suspicious Transplant Cases in Your Organization or Country BKH2004-03 Jonathan WalaAmeyo Speaker jonathanwala@yahoo.comKenyaKenya Renal Association From Identification to Resolution: A Guide to Managing Suspicious Transplant Cases BKH2004-04 YADIRA ANTONIATEHUACANERO TECUA Speaker MexicoSwisstransplant Q&A BKH2004-05 Neelkamal Hall 305	Bridging Gaps in Kidney Disease Diagnostics: Striving for Equity BKH1003 DanielO'Hara Chair AustraliaNHMRC Clinical Trials Centre, Australia MythriShankar Chair IndiaInstitute of Nephrourology YannickNlandu Chair Democratic Republic of CongoKinshasa University Hospital Panel Discussion: Featuring an Expert in Genetics BKH1003-01 Becky MingyaoMa Speaker Hong Kong, ChinaDivision of Nephrology, Department of Medicine, School of Clinical Medicine, University of Hong Kong Panel Discussion: Featuring a Renal Pathologist BKH1003-02 MarekKollar Speaker Czech RepublicClinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine Panel Discussion: Featuring an Expert in CKD Care From India BKH1003-03 PritiMeena Speaker IndiaAll india institute of medical sciences-Bhubaneswar Panel Discussion:Featuring an Expert in CKD Care From Fiji BKH1003-04 Yogeshni Chandra Speaker Fiji Panel Discussion: Featuring an Expert in CKD Care From Nigeria BKH1003-05 ChimezieOkwuonu Speaker NigeriaFederal Medical Center Q and A BKH1003-06 Parijat Hall 201
5:15 p.m. 6 p.m.	Big Data Lab 6 LAB-06 Big Data Lab
5:30 p.m. 6:30 p.m.	Poster Session POS-2 Exhibition Hall	Meet the Experts Kesar Hall 202	ISN Programs Abstract Awards SL16 TusharVachharajani Spotlight Chairperson tvachh@gmail.comUnited StatesJohn D. Dingell Veterans Affairs Medical Center / Wayne State University School of Medicine Do Transforming Growth Factor-β (TGF-β) Isoforms Predict Chronic Kidney Disease Progression Alfred JacksonMeremo Spotlight Speaker Tanzania Epidemiology Of Vascular Access And Role Played By Nephrologists In Nepal NabinBasnet Spotlight Speaker dr.nabinbasnet@gmail.comNepal Prevalence Of Chronic Kidney Disease In Sri Lanka RajithaAbeysekera Spotlight Speaker rajithaasa55@gmail.comSri Lanka Sodium Gradient And All-Cause Mortality In Incident Maintenance Hemodialysis Patients: Results From The Monitoring Dialysis Outcomes (Mondo) Initiative Felix-MihaiMaralescu Spotlight Speaker Romania JC Virus Is Underestimated In Kidney Transplant Recipients MirhaPjanic Spotlight Speaker mirhapjanic93@gmail.comBosnia and Herzegovina Spotlight One (Exhibition)	AI in Nephrology: Hands-On Training Workshop SL17 Augusto CesarSoares dos Santos Junior Spotlight Chairperson BrazilHospital das Clinicas, UFMG; Fac Ciências Medicas HanjieZhang Spotlight Speaker Hanjie.Zhang@rriny.comUnited States PETERKOTANKO Spotlight Speaker Peter.Kotanko@rriny.comUnited States Spotlight Two (Amphitheatre, level 5)

Sunday, February 9, 2025

Time	Session

9 a.m. 10:30 a.m.	Metabolic Crossroads: Kidneys, Liver Disease, and the Gut IK06 GloriaAshuntantang Chair CameroonUniversity of Bamenda, Cameroon Narayan Prasad Chair IndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Dr Sree BhushanRaju Chair sreebhushan@hotmail.comIndia Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis IK06-01 Swetha RaniKanduri Speaker svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it? IK06-02 GrietGlorieux Speaker GRIET.GLORIEUX@UGent.beBelgiumUGent What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease IK06-03 Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Measuring Kidney Function in Liver Disease - Pitfalls and Solutions IK06-04 SmitaDivyaveer Speaker divyaveer.ss@gmail.comIndiaPOST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA Q&A IK06-05 Amaltas Hall B101-A	The Ageing Kidney: Of Neurons and Nephrons IK07 AnupmaKaul Chair anupmaneph@gmail.comIndiaSanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow , India AshwaniGupta Chair ashwani_gupta2002@yahoo.comIndia Mohamad Bassam Said Chair bmsaeed2000@yahoo.comSyrian Arab RepublicFarah Association for Child with Kidney Disease in Syria Defining Accelerated Kidney Ageing IK07-01 AlbertoOrtiz Speaker SpainIIS-Fundacion Jimenez Diaz UAM, Madrid, Spain Accelerated Biological Ageing in CKD: Drivers and Potential Therapeutic Interventions IK07-02 MotokoYanagita Speaker JapanKyoto University The Kidney-Brain Connection IK07-03 MarionPépin Speaker marion.pepin@aphp.frFranceINSERM, CESP UMR 1018, Clinical epidemiology, Paris Saclay University, Villejuif, France/ Geriatric Department, Ambroise Paré Hospital, APHP, Versailles St Quentin University, Boulogne ,France Cognitive Impairment in Kidney Disease IK07-04 VanitaJassal Speaker vanita.jassal@uhn.caCanadaUniversity Health Network, Toronto CANADA Q&A IK07-05 Amaltas Hall B101-B		HIT! High Impact Clinical Trials – Why and How HIT2 DavidWheeler Chair United KingdomUniversity College London Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong What Have We Learned From CONVINCE? HIT2-1 PeterBlankestijn Oral Abstract Presenter P.J.Blankestijn@umcutrecht.nlNetherlandsUniversity Medical Center Utrecht Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease HIT2-2 VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) HIT2-3 Jonathan Barratt Oral Abstract Presenter United KingdomUniversity of Leicester, Leicester, UK Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease HIT2-4 KateBramham Oral Abstract Presenter United KingdomKing's College London Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage HIT2-5 Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore Brahmkamal Hall - Plenary Hall		Enhancing Prevention and Control of Chronic Kidney Conditions and Other Non-Communicable Diseases/Co-Morbidities Through Meaningful Involvement of Lived Experience Champions and Communities HRIDAY MonikaArora Chair monika@hriday-shan.orgIndiaHRIDAY Session Overview and Context HRIDAY-1 MonikaArora Speaker monika@hriday-shan.orgIndiaHRIDAY Pace-setting Presentation: Role of Civil Society in Promoting Leadership of Lived Experience Champions to Augment NCD Services and Programs HRIDAY-2 RadhikaShrivastav Speaker radhika@hriday-shan.orgIndia Keynote Presentation Inclusion of Chronic Kidney Diseases in India's National Programme on Prevention and Control of NCDs (NP-NCD): opportunity for enhanced community engagement HRIDAY-3 ShikhaVardhan Speaker shikha.vardhan@gov.inIndia Panel Discussion: Experience of a Lived Experience Champion in the Management of CKD and Other Underlying Conditions HRIDAY-4 Magdalena Machalska Speaker Belgium PradeepJoshi Speaker joship@who.intIndia SeemaBali Speaker seemabali2015@gmail.comIndiaHealthy India Alliance YangchenDolma Speaker yangchen_dolma@yahoo.comIndiaSenior Nursing Officer, AIIMS New Delhi Open Discussion HRIDAY-5 Summary of Session Highlights HRIDAY-6 MonikaArora Chair monika@hriday-shan.orgIndiaHRIDAY Gulmohar Hall 302		Make It Work Better for Failing Kidneys with Sustainable Care LF06 AjaySingh Chair Ajay_Singh@hms.harvard.eduUnited States ManjuriSharma Chair manjurisharma@yahoo.com IndiaProf. & Head, Dept of Nephrology, Gauhati Medical College & Hospital, Guwahati, Assam Toward a Plant-based Diet in CKD LF06-01 Juan-JesusCarrero Speaker juan.jesus.carrero@ki.seSwedenKarolinska Institutet Why Peritoneal Dialysis Uptake Is Low in Many World Regions and How Can We Fix it? LF06-02 Magdalena Madero Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiologia Ignachi Chavez Improving Dialysis Quality: A Hub-and-Spoke Network LF06-03 ManishaSahay Speaker IndiaProfessor and Head, Department of Nephrology, Osmania Medical college and General hospital, Hyderabad, Telangana, India Kidney Supportive Care in a Low-resource Setting LF06-04 Nicola Wearne Speaker nicola.wearne@uct.ac.zaSouth AfricaGroote Schuur Hospital / university of Cape Town A Working Partnership - Shared Decision-making in Nephrology LF06-05 Ana Elizabeth Figueiredo Speaker BrazilPontifícia Universidade Católica do Rio Grande do Q&A LF06-06 Neelkamal Hall 305
10 a.m. 10:30 a.m.	How to Facilitate Learning Nephrology Among Medical Students, Residents and Fellows Using Hands-On Experiences SL18 Carmen ElenaCervantes Spotlight Chairperson United StatesJohns Hopkins University MarekKollar Spotlight Chairperson Czech RepublicClinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine MythriShankar Spotlight Chairperson IndiaInstitute of Nephrourology Spotlight Two (Amphitheatre, level 5)
10:30 a.m. 11 a.m.	Parenthood in Nephrology: Opportunities and Challenges SL19 Spotlight Two (Amphitheatre, level 5)
11 a.m. 12 p.m.	Equitable Kidney Health- Making it Part of The Day Job SpS-Shiv GavinDreyer Chair United KingdomBarts Health NHS Trust Time to Act on Kidney Health Inequalities in the UK SpS-Shiv-1 Shivani Sharma Speaker s.sharma10@aston.ac.ukUnited Kingdom Targeting Equitable Kidney Health Through the Global Kidney Health Atlas SpS-Shiv-2 ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo Bridging the Access Gap in Rural Communities SpS-Shiv-1 RobertKalyesubula Speaker UgandaMakerere, University Amaltas Hall B101-A		HIT! High Impact Clinical Trials – Study Design HIT3 DilushiWijayaratne Chair Sri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka JAIPRAKASHTIWARI Chair dr_jptiwari@yahoo.inIndiaProfessor and Head, Department of Nephrology, Goa Medical College, Goa, India ;MD, DM Nephrology, FISN, FISOT Findings and Lessons from the PARADIGM Research Consensus Conference HIT3-1 AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care Findings and Lessons from ALIGN Study Design HIT3-2 HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Findings and Lessons from RESOLVE Study Design HIT3-3 MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Findings and Lessons from LIFT Study HIT3-4 DebasishBanerjee Oral Abstract Presenter dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr Q and A Brahmkamal Hall - Plenary Hall		Quiz Session: Indian Society Early Career Nephrologists Quiz-01 ArunkumarSubbiah Host IndiaAll India Institute of Medical Sciences, New Delhi MedhaviGautam Host IndiaMD, GlomCon Fellow, NephEdc Intern , ISN member , India SayaliThakare Host IndiaSeth GSMC and KEM Hospital, Mumbai, India Gulmohar Hall 302		MedEd in the Modern Era: #NephJC at the #ISNWCN IND01 ArvindConjeevaram Chair IndiaHead - Nephrology Dept, Trustwell Hospitals, Bangalore Narayan Prasad Chair IndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India UrmilaAnandh Chair IndiaAmrita Hospitals, Faridabad, Delhi NCR Tweets, Skeets, and Podcasts: Harnessing 21st Century Tools for Medical Education IND01-01 CristinaPopa Speaker RomaniaNephJC Don't Believe Everything You Read: #NephJC style Critical Appraisal IND01-02 SwapnilHiremath Speaker CanadaUniversity of Ottawa Is A Picture Truly Worth a 1000 Words? Visual Abstracts and Infographics IND01-03 DIVYABAJPAI Speaker IndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India Q and A IND01-04 Neelkamal Hall 305
12:15 p.m. 1:15 p.m.	Plenary Session 4: Diabetes and Adipocytokines (Takashi Kadowaki, Japan) PL4 MarcelloTonelli Chair CanadaUniversity of Calgary MasaomiNangaku Chair JapanThe University of Tokyo MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Diabetes and Adipocytokines. Brenner/Dirks Lecture PL4-1 TakashiKadowaki Speaker JapanToranomon Hospital Message from Outgoing ISN President PL4-2 MasaomiNangaku Chair JapanThe University of Tokyo Message from Incoming ISN President PL4-4 MarcelloTonelli Chair CanadaUniversity of Calgary Brahmkamal Hall - Plenary Hall

Thursday, February 6, 2025

Time	Session

9 a.m. 11 a.m.	Hands-on Masterclass in Nephrology: Interventional Nephrology, Dialysis, and POCUS Course - Critical Care and Kidney Biopsy INTV1 AndrewMoses Chair amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health IrmaTchokhonelidze Chair irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University JadrankaButurović Ponikvar Chair jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India SourabhSharma Chair IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Case Study Part 1 and POCUS Kidney and Lungs BLUE Protocol INTV1-01 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health Native and Transplanted Kidney Biopsy INTV1-02 JadrankaButurović Ponikvar Speaker jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Speaker mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India CKRT vs. SLED: Pros and Cons INTV1-03 SourabhSharma Speaker IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Hands-on Training: Kidney Biopsy INTV1-04 JadrankaButurović Ponikvar Speaker jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Speaker mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India Hands-on Training: CKRT and SLED Machine INTV1-05 SourabhSharma Speaker IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Hands-on Training: POCUS Kidney and Lung With BLUE Protocol INTV1-06 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health HildaElena Fernandez Speaker hef2112@cumc.columbia.eduUnited States Amaltas Hall B101-A		Renal Pathology Course: Updates on Regional Diseases PATH1 CarmenAvila Casado Chair carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India SuryaSeshan Chair United StatesWeill Cornell Medicine IgA Nephropathy and IgA Vasculitis PATH1-01 MarkHaas Speaker mark.haas@cshs.orgUnited StatesCedars-Sinai Medical Center Kidney Lesions in Tropical Infections PATH1-02 AhmedKalebi Speaker KenyaDr. Kalebi Labs (DKL) Limited Controversies in Podocytopathies PATH1-03 CarmenAvila Casado Speaker carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN Pregnancy Related Renal Disease PATH1-04 AgnesFogo Speaker United States Q and A PATH1-05 Amaltas Hall B101-B		Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life - Managing Transitions in Transplant and Promoting Adherence AHP1 Ana Elizabeth Figueiredo Chair BrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Chair elaine.bowes@nhs.netUnited KingdomKing's College Hospital ZehraAydin Chair TurkeyIstanbul Atlas University Navigating Post-transplant Dialysis: What to Expect AHP1-01 AngelaJackson Speaker angela.jackson@middlemore.co.nzNew ZealandHealth New Zealand - Counties Manukau From Dialysis to Transplant: Guiding Children Through the Transition AHP1-02 Sandhya VNair Speaker sandya.asokakumar@gmail.comIndiaindian nursing council Meeting the Mark: Adherence Requirements for Transplant Success AHP1-03 Janevan der Jeugd Speaker jane.vanderjeugd@sa.gov.auAustraliaFlinders Medical Centre, Adelaide, South Australia Q&A AHP1-04 Champa Hall 304		Glomerular Disease Course: A Case-based Approach to Renal Histology and Nephrotic Syndrome GN1 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair IndiaChristian Medical College Vellore Approach to Nephrotic Syndrome GN1-01 SuceenaAlexander Speaker IndiaChristian Medical College Vellore Case Presentation and Discussion 1 GN1-02 HeatherReich Speaker CanadaUniversity of Toronto, University Health Network Case Presentation and Discussion 2 GN1-03 Raja Ramachandran Speaker drraja1980@gmail.comIndiaAssociate Professor Gulmohar Hall 302		Conservative Kidney Management Course: Core Principles and Symptom Management CKM1 FrankBrennan Chair AustraliaSt George Hospital NandiniVallath Chair IndiaSt John's Medical College hospital SaraDavison Chair CanadaUniversity of Alberta Introduction to Kidney Supportive Care (KSC) and Conservative Kidney Management (CKM) CKM1-01 SaraDavison Speaker CanadaUniversity of Alberta Validating CKM: Evidence and Approaches CKM1-02 BarnabyHole Speaker United KingdomUniversity of Bristol, UK Effective Strategies for Pharmacologic Pain Management in CKM CKM1-03 SaraDavison Speaker CanadaUniversity of Alberta Addressing Depression and Anxiety in CKM Patients CKM1-04 PeaceBagasha Speaker UgandaMulago National Referral Hospital Q&A CKM1-05 Kumudini Hall 301		Annual Review of Nephrology Course: Managing Kidney Failure NAR1 KenarJhaveri Chair United StatesNorthwell Health MitchellRosner Chair United StatesUniveristy of Virginia Health New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors NAR1-01 JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals NAR1-02 KrishnaswamySampathkumar Speaker drksampath@gmail.comIndiaMeenakshi Mission Hospital Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue? NAR1-03 Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Q and A NAR1-04 Neelkamal Hall 305
11:30 a.m. 1:30 p.m.	Hands-on Masterclass in Nephrology: Interventional Nephrology, Dialysis, and POCUS Course - Hemodialysis and Complications INTV2 AndrewMoses Chair amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health IrmaTchokhonelidze Chair irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University JadrankaButurović Ponikvar Chair jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India SourabhSharma Chair IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Case Study Part 2 and Cardiac POCUS INTV2-1 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health Dialysis Adequacy: Assessing and Improving Outcomes INTV2-2 IrmaTchokhonelidze Speaker irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University Hemodialysis Catheter: Insertion, Exchange, Removal INTV2-3 AnilAGARWAL Speaker akagarwalmd@gmail.comUnited StatesUniversity of California San Francisco, Fresno, US Hands-on Training: HD Catheters: Insertion, Exchange, Removal INTV2-4 AnilAGARWAL Speaker akagarwalmd@gmail.comUnited StatesUniversity of California San Francisco, Fresno, US JeyarajBalasubramaniam Speaker kidneycare@yahoo.comIndiaKidney Care Centre, Tirunelveli, India Hands-on Training: HD/HDF/Home HD Machines: What are the Treatment Options? INTV2-5 IrmaTchokhonelidze Speaker irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University Hands-on Training: Cardiac POCUS INTV2-6 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health HildaElena Fernandez Speaker hef2112@cumc.columbia.eduUnited States Amaltas Hall B101-A		Renal Pathology Course: Recent Advances in Kidney and Transplant Pathology PATH2 CarmenAvila Casado Chair carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India SuryaSeshan Chair United StatesWeill Cornell Medicine Mass Spectrometry for the Diagnosis of Renal Diseases PATH2-1 SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Application of Digital Tools in Renal Pathology PATH2-2 ArvydasLaurinavicius Speaker Arvydas.Laurinavicius@vpc.ltLithuaniaVilnius University The Importance of Medullary Lesions In Kidney Biopsies PATH2-3 JorisRoelofs Speaker j.j.roelofs@amsterdamumc.nlNetherlandsAmsterdam UMC New Insights in Drug Induced Kidney Diseases PATH2-4 SuryaSeshan Speaker United StatesWeill Cornell Medicine Q and A PATH2-5 Amaltas Hall B101-B		Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: Prevention, Diabetic Patients and Acute Care AHP2 Ana Elizabeth Figueiredo Chair BrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Chair elaine.bowes@nhs.netUnited KingdomKing's College Hospital ZehraAydin Chair TurkeyIstanbul Atlas University Enhancing Acute Care: Managing Late Referral Hemodialysis AHP2-01 Ana Elizabeth Figueiredo Speaker BrazilPontifícia Universidade Católica do Rio Grande do Enhancing Acute Care: Managing Urgent Start Peritoneal Dialysis AHP2-02 ElaineBowes Speaker elaine.bowes@nhs.netUnited KingdomKing's College Hospital From Diabetes to Dialysis: Ensuring Smooth Care Transitions AHP2-03 EveNatusch Speaker eve.natusch@hbdhb.govt.nzNew ZealandNurse Practitioner Diabetes and Long-Term Conditions, Secondary Healthcare Services Better Together: Community Approaches to Preventing Chronic Kidney Disease AHP2-04 SulakshnaBharadwaj Speaker sulakshnabharadwaj@yahoo.co.inIndiaINSTITUTE OF LIVER AND BILIARY SCIENCES Q&A AHP2-05 Champa Hall 304		Glomerular Disease Course - A Case-Based Approach: Nephritic Syndrome GN2 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair IndiaChristian Medical College Vellore Approach to Nephritic Syndrome GN2-01 AdrianLiew Speaker SingaporeMount Elizabeth Novena Hospital, Singapore Case Presentation and Discussion 3 GN2-02 Jonathan Barratt Speaker United KingdomUniversity of Leicester, Leicester, UK Case Presentation and Discussion 4 GN2-03 LizLightstone Speaker United KingdomImperial College London Case Presentation and Discussion 5 GN2-04 SuceenaAlexander Speaker IndiaChristian Medical College Vellore Gulmohar Hall 302		Conservative Kidney Management Course: Navigating Symptoms and Metabolic Complications CKM2 FrankBrennan Chair AustraliaSt George Hospital NandiniVallath Chair IndiaSt John's Medical College hospital SaraDavison Chair CanadaUniversity of Alberta Managing CKD-associated Pruritus and Restless Legs Syndrome in CKM CKM2-01 FrankBrennan Speaker AustraliaSt George Hospital Tackling Fatigue and Insomnia in CKM Patients CKM2-02 AnujaDamani Speaker Anuja.damani@manipal.eduIndiaKasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal Managing Nausea and Vomiting in CKM: Best Practices CKM2-03 ClaireDouglas Speaker Claire.Douglas5@nhs.scotUnited KingdomNHS Tayside, Scotland, UK End-of-Life Transition in CKM: Care and Symptom Management CKM2-04 NandiniVallath Speaker IndiaSt John's Medical College hospital Managing Metabolic Complications of CKD in CKM CKM2-05 SaraDavison Speaker CanadaUniversity of Alberta Q&A CKM2-06 Kumudini Hall 301		Annual Review of Nephrology Course: Best Practices in Diabetic Kidney Disease Care NAR2 KenarJhaveri Chair United StatesNorthwell Health MitchellRosner Chair United StatesUniveristy of Virginia Health Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2 NAR2-01 MaartenTaal Speaker maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach NAR2-02 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach NAR2-03 MadhukarMisra Speaker misram@health.missouri.eduUnited StatesUniversity of Missouri Columbia, USA Q and A NAR2-04 Neelkamal Hall 305
1 p.m. 2:25 p.m.	Building a CKDu Research Methodology Toolbox, part 1 i3C-1 ErangaWijewickrama Chair Sri LankaFaculty of Medicine, University of Colombo Study Designs to Answer Research Questions in CKDu i3C-1-01 Magdalena Madero Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiologia Ignachi Chavez Distinguishing CKDu From Other Kidney Diseases in Research Studies i3C-1-02 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Q and A i3C-1-03 Javakusum Hall 303				ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Inspiration from Established Registries in South Asia SHARE RR1 FergusCaskey Chair United KingdomUniversity of Bristol, UK MariaPippias Chair maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol The SharE-RR Toolkit SHARE RR1-001 MariaPippias Speaker maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol The South African Renal Registry: Re-Establishing After 20 Years' Dormancy and Recent Governance Lessons SHARE RR1-002 Mogamat RazeenDavids Speaker South AfricaStellenbosch University and Tygerberg Hospital The Bangladesh Renal Registry: Twenty Years Experience Covering HD, PD, and Transplant SHARE RR1-003 HarunUr Rashid Speaker rashid@bol-online.comBangladeshKidney Foundation Hospital and Research Institute The Indian Renal Registry: Establishing a Multi-centre Dialysis Registry SHARE RR1-004 SumaiyaArfin Speaker sumaiyaarfin@gmail.comIndiaThe George Institute for Global Health, India Q and A SHARE RR1-005 Kesar Hall 202				ISN Train The Trainer Program for Pregnancy and Kidney Disease - Update and Toolkit Launch SS3 MichelleHladunewich Chair CanadaSunnybrook Health Sciences Centre ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and Adelaide University, Australia Welcome and Background on Obstetric Nephrology Evolution SS3-001 MichelleHladunewich Speaker CanadaSunnybrook Health Sciences Centre Overview of the TT Program and Toolkit Launch SS3-002 ShilpanjaliJesudason Speaker AustraliaRoyal Adelaide Hospital and Adelaide University, Australia Trainer Perspective SS3-003 GhadaAnkawi Speaker Saudi ArabiaKing Abdulaziz University Trainer Perspective SS3-004 DIVYABAJPAI Speaker IndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India Panel Discussion, Questions and Group Discussion SS3-005 Mogra Hall A 404
2:15 p.m. 4:15 p.m.	Hands-on Masterclass in Nephrology: Interventional Nephrology, Dialysis, and POCUS Course - Peritoneal Dialysis and Volume INTV3 AndrewMoses Chair amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health IrmaTchokhonelidze Chair irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University JadrankaButurović Ponikvar Chair jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India SourabhSharma Chair IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Case Study Part 3 and VExUS Technique INTV3-1 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health PD Catheter Insertion INTV3-2 KrishnaswamySampathkumar Speaker drksampath@gmail.comIndiaMeenakshi Mission Hospital Urgent Initiation of PD: Challenges and Solutions INTV3-3 BrettCullis Speaker brett.cullis@gmail.comSouth AfricaUniversity of Cape Town Hands-on Training: APD Machine Prescription Options INTV3-4 IrmaTchokhonelidze Speaker irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University KrishnaswamySampathkumar Speaker drksampath@gmail.comIndiaMeenakshi Mission Hospital Hands-on Training: PD Catheter Insertion INTV3-5 BrettCullis Speaker brett.cullis@gmail.comSouth AfricaUniversity of Cape Town Hands-on Training: VExUS INTV3-6 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health HildaElena Fernandez Speaker hef2112@cumc.columbia.eduUnited States Case 3 INTV3-7 Amaltas Hall B101-A	Renal Pathology Course: Clinical-Pathologic Correlation Case Presentations PATH3 CarmenAvila Casado Chair carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India SuryaSeshan Chair United StatesWeill Cornell Medicine Nephrologist, Clinical Discussant - Case 1 PATH3-01 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 1 PATH3-02 GeetikaSingh Speaker ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India Nephrologist, Clinical Discussant - Case 2 PATH3-03 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 2 PATH3-04 AnilaKurien Speaker anila_abraham08@yahoo.comIndiaRenopath, Center for Renal and Urological Pathology, Chennai, India Nephrologist, Clinical Discussant - Case 3 PATH3-05 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 3 PATH3-06 JorisRoelofs Speaker j.j.roelofs@amsterdamumc.nlNetherlandsAmsterdam UMC Nephrologist, Clinical Discussant - Case 4 PATH3-07 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 4 PATH3-08 CarmenAvila Casado Speaker carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN Nephrologist, Clinical Discussant - Case 5 PATH3-09 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 5 PATH3-10 ArvydasLaurinavicius Speaker Arvydas.Laurinavicius@vpc.ltLithuaniaVilnius University Nephrologist, Clinical Discussant - Case 6 PATH3-11 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 6 PATH3-12 MaheshaVankalakunti Speaker mahesha.vankalakunti@manipalhospitals.comIndiaManipal Hospitals, Bengaluru Amaltas Hall B101-B		Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: Supporting Patients at Home AHP3 Ana Elizabeth Figueiredo Chair BrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Chair elaine.bowes@nhs.netUnited KingdomKing's College Hospital ZehraAydin Chair TurkeyIstanbul Atlas University How Frail Is Too Frail? Addressing Frailty in Home Hemodialysis Patients AHP3-01 RachaelWalker Speaker New ZealandUniversity of Auckland, New Zealand Fostering Independence: Supporting Patients to Manage Home Dialysis AV-fistulas AHP3-02 Fatimade Figueiredo Speaker f.defigueiredo@nhs.netUnited Kingdom Mastering Nutrition: Optimal Diet for Managing Diabetic Kidney Disease AHP3-03 GurdeepKaur Speaker gur1305@gmail.comIndiaMSc, RD Q&A AHP3-04 Champa Hall 304		Glomerular Disease Course: Case-based Approach to Rapidly Progressive Glomerulonephritis and Glomerular Diseases in Acute Kidney Injury GN3 AdrianLiew Chair SingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair IndiaChristian Medical College Vellore Approach to Rapidly Progressive Glomerulonephritis GN3-01 Raja Ramachandran Speaker drraja1980@gmail.comIndiaAssociate Professor Case Presentation and Discussion 6 GN3-02 HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Case Presentation and Discussion 7 GN3-03 Muh GeotWong Speaker Australia Case Presentation and Discussion 8 GN3-04 AdrianLiew Speaker SingaporeMount Elizabeth Novena Hospital, Singapore Gulmohar Hall 302		Conservative Kidney Management Course: Shared Decision-making, Communication Skills and Capacity Building for End-of-Life Care CKM3 FrankBrennan Chair AustraliaSt George Hospital NandiniVallath Chair IndiaSt John's Medical College hospital SaraDavison Chair CanadaUniversity of Alberta Shared Decision-making and Cultural Considerations in CKM CKM3-01 SaharKoubar Speaker United StatesUniversity of Minnesota Essential Communication Skills and Advance Care Planning in CKM (Interactive Workshop) CKM3-02 AmarBansal Speaker bansalad@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine Practical Challenges in Implementing CKM: Cultural and Resource Considerations From India CKM3-03 NandiniVallath Speaker IndiaSt John's Medical College hospital Q&A CKM3-04 Kumudini Hall 301		Annual Review of Nephrology Course: Electrolyte Management in the ICU NAR3 KenarJhaveri Chair United StatesNorthwell Health MitchellRosner Chair United StatesUniveristy of Virginia Health Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury NAR3-01 MitchellRosner Speaker United StatesUniveristy of Virginia Health Approaches to Severe Hypercalcemia NAR3-02 KenarJhaveri Speaker United StatesNorthwell Health Approaches to Severe Hyperkalemia NAR3-03 KSNayak Speaker drksnayak@gmail.comIndiaVirinchi Hospitals Q and A NAR3-04 Neelkamal Hall 305		Professor Donal O'Donoghue Global Kidney Policy Forum: Opening Remarks and Setting the Scene PF1 IfeomaUlasi Chair NigeriaCollege of Medicine, University of Nigeria Opening Remarks PF1-01 IfeomaUlasi Chair NigeriaCollege of Medicine, University of Nigeria Patient Testimony: Living with a Kidney Disease PF1-02 VikramVuppala Speaker vikram@nephroplus.comIndiaNephroPlus Parijat Hall 201
2:35 p.m. 4 p.m.	Building a CKDu Research Methodology Toolbox, part 2 i3C-2 ErangaWijewickrama Chair Sri LankaFaculty of Medicine, University of Colombo What Should We Measure to Identify Disease in CKDu Research? i3C-2-01 BenCaplin Speaker b.caplin@ucl.ac.ukUnited KingdomUniversity College London How Can Kidney Biopsies Provide Causal Insight Into CKDu? i3C-2-02 ShuchiAnand Speaker United States Q and A Javakusum Hall 303						Professor Donal O'Donoghue Global Kidney Policy Forum: Local Voices, Global Impact: Tackling Kidney Health Challenges in India PF2 VivekanandJha Chair IndiaGeorge Institute for Global Health India Introducing Local Voices PF2-01 VivekanandJha Chair IndiaGeorge Institute for Global Health India Kidney Health in India: A Comprehensive Overview PF2-02 SanghamitraPati Speaker drsanghamitra12@gmail.comIndiaAdditional Director General, ICMR, New Delhi Collective Action Towards Integrated Care: Learning from National NCD Program PF2-03 MonikaArora Speaker monika@hriday-shan.orgIndiaHRIDAY Kidney Health in India: Importance of Measurement, Quality Assurance, and Registries PF2-04 ManishaSahay Speaker IndiaProfessor and Head, Department of Nephrology, Osmania Medical college and General hospital, Hyderabad, Telangana, India Home Dialysis: Navigating Challenges and Opportunities PF2-05 Magdalena Madero Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiologia Ignachi Chavez Q and A PF2-05 Parijat Hall 201
2:45 p.m. 4:05 p.m.	ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Using Registries to Support Clinical Trials SHARE RR2 MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and Adelaide University, Australia Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia SHARE RR2-001 RachaelMorton Speaker rachael.morton@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, The University of Sydney Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data SHARE RR2-002 Juan-JesusCarrero Speaker juan.jesus.carrero@ki.seSwedenKarolinska Institutet Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK SHARE RR2-003 FergusCaskey Speaker United KingdomUniversity of Bristol, UK Q and A SHARE RR2-004 Kesar Hall 202
3:20 p.m. 4:05 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: From Barriers to Solutions: Advancing Access to Kidney Care Across the Region PF3 UrmilaAnandh Chair IndiaAmrita Hospitals, Faridabad, Delhi NCR Introducing Voices from the Region PF3-01 UrmilaAnandh Chair IndiaAmrita Hospitals, Faridabad, Delhi NCR Kidney Health in the Region: Trends, Challenges, and WHO Initiatives for Improved Care PF3-02 NalikaGunawardena Speaker gunawardenan@who.intIndiaWHO South-East Asia Regional Office From Access to Accountability: Lessons from Thailand's Case Study on Kidney Care Policies PF3-03 YotTeerawattananon Speaker yot.t@hitap.netThailandHITAP The Role of Public-Private Partnerships in Dialysis Care and the Impact of Climate Change on Kidney Health in Bangladesh PF3-04 Kazi ShahnoorAlam Speaker ofaroque68@gmail.comBangladeshProfessor of Nephrology National Institute of Kidney Diseases and Urology, Dhaka, Bangladesh. Sri Lanka: Tackling the Socio-Economic Determinants of Chronic Kidney Disease of Unknown Etiology (CKDu) PF3-05 DilushiWijayaratne Speaker Sri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka Community-Based Screening through the Kidney Care Network in Nepal PF3-06 Sanjib KumarSharma Speaker NepalBP Koirala Institute of Health Sciences Q and A PF3-07 Parijat Hall 201
4:05 p.m. 4:15 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Closing Remarks and Next Steps PF4 IfeomaUlasi Chair NigeriaCollege of Medicine, University of Nigeria Closing Remarks PF4-01 IfeomaUlasi Chair NigeriaCollege of Medicine, University of Nigeria Advancing Kidney Health: Insights from Patient Advocates PF4-02 VasundharaRaghavan Speaker vasundhara.raghavan@gmail.comIndiaMember of PLAG Parijat Hall 201
4:30 p.m. 6 p.m.	Plenary Session 1 and WCN'25 Opening Ceremony OCPL1 Welcome and ISN Presidential Address OCPL-1 MasaomiNangaku Speaker JapanThe University of Tokyo Science with a Purpose: Equity, Accountability and Sustainability in Kidney Care (Panel Discussion) OCPL-2 LizLightstone Moderator United KingdomImperial College London GautamiTadimalla Speaker gtadimalla@gmail.comIndiaLife Again Foundation NicoleScholes-Robertson Speaker AustraliaThe University of Sydney RadhikaCoomaraswamy Speaker rcoomaraswamy@yahoo.comSri LankaFormer Under Secretary General of the United Nations Congress Welcome by the Indian Society of Nephrology OCPL-3 Shyam BihariBansal Speaker IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Brahmkamal Hall - Plenary Hall
6:45 p.m. 7:30 p.m.	Spotlight on Global Kidney Health: Interactive Mapping and Key Insights SL01 AminuBello Spotlight Chairperson CanadaUniversity of Alberta ISN-GKHA: Advancing Global Kidney Health – Updates and Achievements SL01-01 AminuBello Spotlight Speaker CanadaUniversity of Alberta Insights into Global Kidney Health Disparities: A Regional Perspective Using the Interactive Map SL01-02 ErangaWijewickrama Spotlight Speaker Sri LankaFaculty of Medicine, University of Colombo The ISN-GKHA Interactive Map: Bridging Gaps Through Data-Driven Action SL01-03 SomkanyaTungsanga Spotlight Speaker CanadaChulalongkorn University, Bangkok, Thailand; University of Alberta, AB, Canada Spotlight One (Exhibition)						Spotlight on How To Make Your Renal Unit Green ELP SL01A Winston Wing ShingFung Spotlight Chairperson Hong Kong, ChinaPrince of Wales Hospital, Hong Kong DIVYABAJPAI Spotlight Speaker IndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India EhabHafiz Spotlight Speaker EgyptTheodor Bilharz Research Institute Winston Wing ShingFung Spotlight Speaker Hong Kong, ChinaPrince of Wales Hospital, Hong Kong Spotlight Two (Amphitheatre, level 5)